Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Annexin A6 | 6 | 2022 | 17 | 3.800 |
Why?
|
| Breast Neoplasms | 10 | 2017 | 1502 | 1.190 |
Why?
|
| Calcium | 5 | 2022 | 480 | 1.120 |
Why?
|
| Receptors, Calcium-Sensing | 3 | 2017 | 14 | 1.090 |
Why?
|
| Cell Line, Tumor | 16 | 2022 | 2231 | 0.940 |
Why?
|
| Exosomes | 7 | 2018 | 101 | 0.850 |
Why?
|
| Hypercalcemia | 1 | 2022 | 13 | 0.830 |
Why?
|
| Calcium Channels | 2 | 2020 | 76 | 0.760 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2020 | 3 | 0.730 |
Why?
|
| Cell Adhesion | 7 | 2020 | 212 | 0.700 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 194 | 0.660 |
Why?
|
| Signal Transduction | 8 | 2022 | 1908 | 0.560 |
Why?
|
| Blood Proteins | 3 | 2010 | 66 | 0.540 |
Why?
|
| Cell Proliferation | 8 | 2020 | 1198 | 0.510 |
Why?
|
| Focal Adhesions | 2 | 2014 | 15 | 0.510 |
Why?
|
| Quinazolines | 1 | 2013 | 33 | 0.460 |
Why?
|
| Protein Kinase C | 2 | 2004 | 120 | 0.460 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 807 | 0.450 |
Why?
|
| Humans | 32 | 2023 | 37093 | 0.440 |
Why?
|
| alpha-Fetoproteins | 2 | 2022 | 31 | 0.430 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 222 | 0.410 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 307 | 0.370 |
Why?
|
| Carcinoma | 1 | 2010 | 96 | 0.360 |
Why?
|
| Cell Movement | 7 | 2020 | 571 | 0.350 |
Why?
|
| alpha-Defensins | 2 | 2021 | 17 | 0.340 |
Why?
|
| Female | 15 | 2023 | 20969 | 0.320 |
Why?
|
| Onchocerca volvulus | 2 | 1997 | 5 | 0.310 |
Why?
|
| Prognosis | 2 | 2020 | 739 | 0.300 |
Why?
|
| Parathyroid Glands | 3 | 2004 | 5 | 0.290 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 54 | 0.280 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 122 | 0.270 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 803 | 0.270 |
Why?
|
| Parathyroid Hormone | 2 | 2004 | 37 | 0.270 |
Why?
|
| Histones | 2 | 2018 | 190 | 0.260 |
Why?
|
| Carrier Proteins | 1 | 2007 | 305 | 0.250 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 433 | 0.230 |
Why?
|
| Hypogonadism | 1 | 2023 | 21 | 0.230 |
Why?
|
| Hydroxyurea | 1 | 2023 | 34 | 0.220 |
Why?
|
| Colitis, Ulcerative | 2 | 2021 | 54 | 0.220 |
Why?
|
| Crohn Disease | 2 | 2021 | 63 | 0.220 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 13 | 0.220 |
Why?
|
| Colon | 2 | 2021 | 103 | 0.210 |
Why?
|
| Mentors | 1 | 2023 | 127 | 0.210 |
Why?
|
| Protein Precursors | 1 | 2002 | 61 | 0.200 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 213 | 0.200 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 69 | 0.200 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 126 | 0.200 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 59 | 0.200 |
Why?
|
| Acetylcysteine | 1 | 2002 | 62 | 0.200 |
Why?
|
| Oxygen | 1 | 2022 | 207 | 0.200 |
Why?
|
| Enterotoxins | 1 | 2021 | 33 | 0.190 |
Why?
|
| Animals | 12 | 2023 | 15081 | 0.190 |
Why?
|
| Organoids | 1 | 2021 | 22 | 0.190 |
Why?
|
| Glucose | 1 | 2022 | 230 | 0.190 |
Why?
|
| Phosphorylation | 2 | 2019 | 928 | 0.190 |
Why?
|
| Cell Nucleus | 3 | 2018 | 366 | 0.190 |
Why?
|
| Cell Survival | 2 | 2019 | 864 | 0.180 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 62 | 0.180 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 33 | 0.180 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 90 | 0.180 |
Why?
|
| Calcium Channel Blockers | 1 | 2020 | 56 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 251 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 461 | 0.180 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 172 | 0.160 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 219 | 0.160 |
Why?
|
| Syndecan-4 | 1 | 2018 | 4 | 0.160 |
Why?
|
| Durapatite | 1 | 2018 | 17 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1518 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 2 | 2010 | 169 | 0.160 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 77 | 0.160 |
Why?
|
| Mice | 5 | 2023 | 5913 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 190 | 0.160 |
Why?
|
| Retrospective Studies | 3 | 2021 | 2026 | 0.150 |
Why?
|
| Cell Membrane | 4 | 2018 | 381 | 0.150 |
Why?
|
| Neoplasms | 3 | 2018 | 1103 | 0.150 |
Why?
|
| Age of Onset | 1 | 2017 | 100 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 77 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 114 | 0.150 |
Why?
|
| Astrocytoma | 1 | 2016 | 14 | 0.140 |
Why?
|
| Gene Frequency | 1 | 2017 | 195 | 0.140 |
Why?
|
| Helminth Proteins | 1 | 1997 | 25 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 893 | 0.140 |
Why?
|
| Amino Acids | 1 | 1997 | 145 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 92 | 0.140 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 111 | 0.130 |
Why?
|
| Antigens, Helminth | 2 | 1997 | 34 | 0.130 |
Why?
|
| Cattle | 3 | 2013 | 477 | 0.130 |
Why?
|
| Genotype | 1 | 2017 | 730 | 0.130 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2004 | 14 | 0.120 |
Why?
|
| RNA Interference | 2 | 2018 | 243 | 0.120 |
Why?
|
| Gene Expression | 2 | 2016 | 674 | 0.120 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1130 | 0.120 |
Why?
|
| Male | 7 | 2023 | 20025 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2018 | 318 | 0.120 |
Why?
|
| Cell Line | 3 | 2014 | 1354 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2007 | 435 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 83 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 113 | 0.110 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 113 | 0.110 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 29 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2004 | 444 | 0.110 |
Why?
|
| Lysosomes | 1 | 2013 | 91 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2013 | 60 | 0.110 |
Why?
|
| Proteomics | 2 | 2021 | 325 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 767 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 78 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 935 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 128 | 0.110 |
Why?
|
| Cell Nucleus Shape | 1 | 2012 | 1 | 0.100 |
Why?
|
| Breast | 1 | 2013 | 135 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 178 | 0.100 |
Why?
|
| Onchocerca | 1 | 1990 | 4 | 0.090 |
Why?
|
| Glycerol | 1 | 2010 | 28 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 643 | 0.090 |
Why?
|
| Ions | 1 | 2010 | 61 | 0.090 |
Why?
|
| Hela Cells | 2 | 2012 | 366 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 70 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 208 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 197 | 0.080 |
Why?
|
| Endocytosis | 2 | 2020 | 113 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 146 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 182 | 0.070 |
Why?
|
| Contractile Proteins | 1 | 2007 | 8 | 0.070 |
Why?
|
| Replication Origin | 1 | 2007 | 14 | 0.070 |
Why?
|
| G1 Phase | 1 | 2007 | 33 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2010 | 517 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 69 | 0.070 |
Why?
|
| Sequence Analysis, Protein | 1 | 2007 | 50 | 0.070 |
Why?
|
| DNA Helicases | 1 | 2007 | 41 | 0.070 |
Why?
|
| Time Factors | 2 | 2004 | 1742 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 131 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 1180 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1568 | 0.070 |
Why?
|
| Protein Binding | 2 | 2007 | 972 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2007 | 151 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2007 | 201 | 0.070 |
Why?
|
| Protein Transport | 1 | 2007 | 302 | 0.070 |
Why?
|
| Chromatin | 1 | 2007 | 169 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 515 | 0.060 |
Why?
|
| Neomycin | 1 | 2004 | 5 | 0.060 |
Why?
|
| Maleimides | 1 | 2004 | 13 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 41 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2004 | 45 | 0.060 |
Why?
|
| Cations | 1 | 2004 | 45 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 77 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 229 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2004 | 10 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2004 | 176 | 0.060 |
Why?
|
| Carbazoles | 1 | 2004 | 42 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2004 | 130 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2014 | 47 | 0.060 |
Why?
|
| Laminin | 2 | 2014 | 61 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 136 | 0.060 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2003 | 3 | 0.060 |
Why?
|
| Sperm Motility | 1 | 2023 | 38 | 0.060 |
Why?
|
| Indoles | 1 | 2004 | 158 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 539 | 0.060 |
Why?
|
| Plasminogen | 2 | 2013 | 10 | 0.060 |
Why?
|
| Fertility | 1 | 2023 | 59 | 0.060 |
Why?
|
| Semen | 1 | 2023 | 51 | 0.060 |
Why?
|
| Middle Aged | 1 | 2017 | 10129 | 0.060 |
Why?
|
| Faculty | 1 | 2023 | 94 | 0.050 |
Why?
|
| Disease Progression | 2 | 2018 | 601 | 0.050 |
Why?
|
| Brefeldin A | 1 | 2002 | 4 | 0.050 |
Why?
|
| Chloroquine | 1 | 2002 | 19 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 47 | 0.050 |
Why?
|
| Testis | 1 | 2023 | 187 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 59 | 0.050 |
Why?
|
| Calpain | 1 | 2002 | 35 | 0.050 |
Why?
|
| Spermatogenesis | 1 | 2023 | 155 | 0.050 |
Why?
|
| Kidney | 1 | 2004 | 337 | 0.050 |
Why?
|
| Peptides | 2 | 1997 | 320 | 0.050 |
Why?
|
| Mucin-6 | 1 | 2021 | 7 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 114 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 103 | 0.050 |
Why?
|
| Health Personnel | 1 | 2023 | 228 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 360 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2021 | 90 | 0.050 |
Why?
|
| Mutation | 1 | 2004 | 1095 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2018 | 35 | 0.040 |
Why?
|
| Nordefrin | 1 | 2018 | 1 | 0.040 |
Why?
|
| Leupeptins | 1 | 2018 | 11 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2018 | 25 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 35 | 0.040 |
Why?
|
| Half-Life | 1 | 2018 | 54 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2018 | 51 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 51 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2018 | 59 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 34 | 0.040 |
Why?
|
| Protein Stability | 1 | 2018 | 45 | 0.040 |
Why?
|
| Sulfur Radioisotopes | 1 | 1997 | 7 | 0.040 |
Why?
|
| Autoradiography | 1 | 1997 | 36 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1997 | 52 | 0.040 |
Why?
|
| Electrophoresis | 1 | 1997 | 22 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 923 | 0.040 |
Why?
|
| Students | 1 | 2023 | 519 | 0.040 |
Why?
|
| Methionine | 1 | 1997 | 30 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 218 | 0.040 |
Why?
|
| Culture Media | 1 | 1997 | 90 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2021 | 384 | 0.040 |
Why?
|
| Hydroxylation | 1 | 1997 | 15 | 0.040 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2017 | 19 | 0.040 |
Why?
|
| Muramidase | 1 | 2017 | 22 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 252 | 0.040 |
Why?
|
| Ligands | 1 | 2018 | 349 | 0.040 |
Why?
|
| Light | 1 | 2018 | 187 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 295 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 217 | 0.040 |
Why?
|
| Biopsy | 1 | 2017 | 164 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 122 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 173 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 337 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 2014 | 10 | 0.030 |
Why?
|
| Heparin | 1 | 2014 | 35 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 2014 | 23 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 66 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2014 | 143 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2013 | 111 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 626 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 90 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2013 | 98 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 93 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 76 | 0.030 |
Why?
|
| Collagen | 1 | 2013 | 172 | 0.030 |
Why?
|
| Replication Protein A | 1 | 2012 | 8 | 0.030 |
Why?
|
| Annexins | 1 | 2011 | 6 | 0.030 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2011 | 7 | 0.030 |
Why?
|
| Centrosome | 1 | 2012 | 28 | 0.030 |
Why?
|
| beta-Cyclodextrins | 1 | 2011 | 24 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 409 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1371 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 186 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 185 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 152 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2010 | 13 | 0.020 |
Why?
|
| Onchocerciasis | 1 | 1990 | 6 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1990 | 35 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1990 | 43 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 167 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 326 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 399 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1990 | 106 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 6741 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 859 | 0.020 |
Why?
|
| Skin | 1 | 1990 | 174 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 677 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 617 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 933 | 0.020 |
Why?
|
| Crystallization | 1 | 2007 | 86 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 441 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2007 | 191 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 286 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 265 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 325 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2007 | 389 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1609 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 997 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2007 | 453 | 0.010 |
Why?
|
| Surface Plasmon Resonance | 1 | 2003 | 20 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 50 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 93 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 269 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 127 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 408 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 206 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 651 | 0.010 |
Why?
|